| 21/506 |
Incidences of Carbapenemases |
| 21/505 |
Insourcing & Outsourcing |
| 21/504 |
Redeployment of Technology Platform |
| 21/502 |
Systems |
| 21/500 |
Recruitment and Retention Premia |
| 21/499 |
Pregnancy & Covid |
| 21/498 |
Neurology Contacts |
| 21/496 |
Dermatology Treatment Drugs |
| 21/495 |
Trust Artwork |
| 21/494 |
SELR Exemption and MTI Route |
| 21/493 |
Digital Dictation-Speech Recognition Solutions |
| 21/492 |
PET-CT Access |
| 21/490 |
Hospital Admissions |
| 21/489 |
Treatment of Neurology Patients |
| 21/487 |
Drug Treatments |
| 21/486 |
PAS-EPR |
| 21/485 |
Biologics Drugs |
| 21/484 |
Trust Spending On Unlicensed Medicine |
| 21/483 |
Bariatric Equipment |
| 21/479 |
Patient Feeding and Retail Catering |
